Veralto Corp·4

Mar 3, 5:10 PM ET

Kapity Melissa 4

4 · Veralto Corp · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Veralto (VLTO) SVP Melissa Kapity Exercises Options, Sells Shares

What Happened

  • Melissa Kapity, SVP, Water Quality at Veralto (VLTO), exercised stock options and sold common shares in late Feb 2026, and received a grant of restricted stock units (RSUs) on Mar 1, 2026.
  • She exercised 9,744 option shares (2,639 + 7,105) at $83.23 per share, for an aggregate exercise cost of $810,993. On 2026-02-27 she sold 14,840 shares in open-market transactions (5,096; 2,639; 7,105) at $96.60 each, producing gross sale proceeds of $1,433,544. She was also granted RSUs totaling 19,704 shares (reported Mar 1, 2026) that vest per the grant terms (see footnote).

Key Details

  • Transaction dates and prices:
    • 2026-02-27: Exercised options—2,639 shares @ $83.23 ($219,644) and 7,105 shares @ $83.23 ($591,349).
    • 2026-02-27: Open-market sales—5,096 shares @ $96.60 ($492,274); 2,639 shares @ $96.60 ($254,927); 7,105 shares @ $96.60 ($686,343). Total sales ≈ $1,433,544.
    • 2026-03-01: Grant of RSUs reported as acquisitions (4,491 and 15,213 shares) — total 19,704 RSUs, reported at $0 (non-cash award).
  • Shares owned after the transactions: Not specified in the provided excerpt of the filing.
  • Footnotes of note:
    • F1: RSUs payable solely in common stock; vesting—one half on each of the 3rd and 4th anniversaries of Mar 1, 2026.
    • F2: Indicates certain stock options are fully vested.
    • F3: For another option grant, one half becomes exercisable on each of the 3rd and 4th anniversaries (Mar 1, 2026 grant date).
  • Timeliness: Filing dated 2026-03-03 covering transactions on 2026-02-27 and 2026-03-01 — filed within the two-business-day Form 4 window (not marked late).

Context

  • The filing shows an exercise of options followed by open-market sales of shares. This pattern can reflect exercising vested options and selling some or all resulting shares (often to cover exercise cost/taxes or for liquidity); the filing itself does not state motivation.
  • RSU grants are awards with future vesting and do not represent immediately marketable shares; half of the RSUs vest on the third and fourth anniversaries of the Mar 1, 2026 grant date.
  • Derivative/option codes: "M" entries indicate option exercise/conversion; "S" indicates sale; "A" indicates award/grant.

Insider Transaction Report

Form 4
Period: 2026-02-27
Kapity Melissa
SVP, Water Quality
Transactions
  • Sale

    Common Stock

    2026-02-27$96.60/sh5,096$492,27410,224 total
  • Exercise/Conversion

    Common Stock

    2026-02-27$83.23/sh+2,639$219,64412,863 total
  • Sale

    Common Stock

    2026-02-27$96.60/sh2,639$254,92710,224 total
  • Exercise/Conversion

    Common Stock

    2026-02-27$83.23/sh+7,105$591,34917,329 total
  • Sale

    Common Stock

    2026-02-27$96.60/sh7,105$686,34310,224 total
  • Award

    Common Stock

    [F1]
    2026-03-01+4,49114,715 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F2]
    2026-02-272,63913,192 total
    Exercise: $83.23Exp: 2033-02-24Common Stock (2,639 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F2]
    2026-02-277,10528,414 total
    Exercise: $83.23Exp: 2033-02-24Common Stock (7,105 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    [F3]
    2026-03-01+15,21315,213 total
    Exercise: $97.43Exp: 2036-03-01Common Stock (15,213 underlying)
Footnotes (3)
  • [F1]On the date indicated, Veralto Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One half of the RSUs vest on each of the third and fourth anniversaries of the grant date, which is March 1, 2026.
  • [F2]Represents stock options that are fully vested.
  • [F3]One half of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is March 1, 2026.
Signature
/s/ James Tanaka, as attorney-in-fact|2026-03-03

Documents

1 file
  • 4
    wk-form4_1772575850.xmlPrimary

    FORM 4